It won't replace pathologists but it will change the field's dynamics. The overall diagnosis will probably still be done by paths, but the grading/counting mitoses scut might be done by computers. I welcome this change.
We've relied on H&E for too long, as if its the only possible way to diagnose, without more research into other complementary or better modalities. Most of the academic research concerns IHC patterns, but very little of it is higher-end stuff like this.
My biggest concern is that other fields will adopt these new technologies as their own, like what is happening with in-vivo microscopy, further reducing our market share in medicine. Pathology isn't doing much in regards to research in these new, exciting fields.